2023-2029 Global Keratolytic Agents Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 150 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Keratolytic Agents should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Keratolytic Agents market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Keratolytic Agents market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Salicylic Acid segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Psoriasis has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Keratolytic Agents include Pfizer Inc, GSK plc, Novartis AG, Mylan NV, Boehringer Ingelheim International GmbH, AstraZeneca, Johnson & Johnson Private Limited, Bayer AG and Merck & Co., Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Keratolytic agents are the type of compounds which break down the outer layer of skin and minimize the thickness of skin damage cells with the help of exfoliation. These agents are applied to soften the skin and is useful in treating several dry skin conditions.
This report aims to provide a comprehensive study of the global market for Keratolytic Agents. Report Highlights:
(1) Global Keratolytic Agents market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Keratolytic Agents market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Keratolytic Agents market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Keratolytic Agents segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Keratolytic Agents segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Keratolytic Agents, capacity, production and trends.
(7) Keratolytic Agents industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Salicylic Acid
Alpha Hydroxy Acid
Azelaic Acid
Tretinoin
Other
Market segment by application, can be divided into
Psoriasis
Acne
Other
Market segment by players, this report covers
Pfizer Inc
GSK plc
Novartis AG
Mylan NV
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Bayer AG
Merck & Co., Inc
Bristol-Myers Squibb Company
Cadila Pharmaceuticals
Lilly
LEO Pharma A/S
Cipla Inc
Aurobindo Pharma
Lupin
Sumitomo Corporation
Taro Pharmaceutical Industries Ltd

1 Market Overview
1.1 Keratolytic Agents Definition
1.2 Global Keratolytic Agents Market Size and Forecast
1.2.1 By Revenue, Global Keratolytic Agents Market Size, 2018-2029
1.2.2 By Sales Volume, Global Keratolytic Agents Market Size, 2018-2029
1.2.3 Global Keratolytic Agents Price Trend, 2018-2029
1.3 China Keratolytic Agents Market Size and Forecast
1.3.1 By Revenue, China Keratolytic Agents Market Size, 2018-2029
1.3.2 By Sales Volume, China Keratolytic Agents Market Size, 2018-2029
1.3.3 China Keratolytic Agents Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Keratolytic Agents Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Keratolytic Agents Share in Global Market, 2018-2029
1.4.3 Keratolytic Agents Market Size: China VS Global, 2018-2029
1.5 Keratolytic Agents Market Dynamics
1.5.1 Keratolytic Agents Market Drivers
1.5.2 Keratolytic Agents Market Restraints
1.5.3 Keratolytic Agents Industry Trends
1.5.4 Keratolytic Agents Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Keratolytic Agents Revenue by Company, 2018-2023
2.2 Global Keratolytic Agents Sales Volume by Company, 2018-2023
2.3 Global Keratolytic Agents Price by Company, 2018-2023
2.4 Global Keratolytic Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Keratolytic Agents Concentration Ratio
2.6 Global Keratolytic Agents Mergers & Acquisitions, Expansion Plans
2.7 Global Keratolytic Agents Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Keratolytic Agents Revenue by Company, 2018-2023
3.2 China Keratolytic Agents Sales Volume by Company, 2018-2023
3.3 China Keratolytic Agents Keratolytic Agents Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Keratolytic Agents Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Keratolytic Agents Domestic VS Export
3.6 China Market, Keratolytic Agents Import & Export
3.6.1 China Market, Keratolytic Agents Import & Export, 2018-2029
3.6.2 China Keratolytic Agents Import & Export Trends
3.6.3 Main Sources of China Keratolytic Agents Import
3.6.4 Export Destination of China Keratolytic Agents
4 Keratolytic Agents Production by Region
4.1 Global Keratolytic Agents Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Keratolytic Agents Manufacturers
4.3 Global Major Manufacturers, Keratolytic Agents Capacity Expansion and Future Plans
4.4 Global Keratolytic Agents Capacity by Region
4.5 Global Keratolytic Agents Production by Region
4.5.1 Global Keratolytic Agents Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Keratolytic Agents Production by Region, 2018-2023
4.5.3 Global Keratolytic Agents Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Keratolytic Agents Industry Chain
5.2 Keratolytic Agents Upstream Analysis
5.2.1 Keratolytic Agents Core Raw Materials
5.2.2 Main Manufacturers of Keratolytic Agents Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Keratolytic Agents Production Mode
5.6 Keratolytic Agents Procurement Model
5.7 Keratolytic Agents Industry Sales Model and Sales Channels
5.7.1 Keratolytic Agents Sales Model
5.7.2 Keratolytic Agents Typical Distributors
6 Sights by Type
6.1 Keratolytic Agents Classification
6.1.1 Salicylic Acid
6.1.2 Alpha Hydroxy Acid
6.1.3 Azelaic Acid
6.1.4 Tretinoin
6.1.5 Other
6.2 By Type, Global Keratolytic Agents Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Keratolytic Agents Revenue, 2018-2029
6.4 By Type, Global Keratolytic Agents Sales Volume, 2018-2029
6.5 By Type, Global Keratolytic Agents Price, 2018-2029
7 Sights by Application
7.1 Keratolytic Agents Segment by Application
7.1.1 Psoriasis
7.1.2 Acne
7.1.3 Other
7.2 By Application, Global Keratolytic Agents Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Keratolytic Agents Revenue, 2018-2029
7.4 By Application, Global Keratolytic Agents Sales Volume, 2018-2029
7.5 By Application, Global Keratolytic Agents Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Keratolytic Agents Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Keratolytic Agents Revenue, 2018-2029
8.3 By Region, Global Keratolytic Agents Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Keratolytic Agents Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Keratolytic Agents Market Size Market Share
8.5 Europe
8.5.1 Europe Keratolytic Agents Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Keratolytic Agents Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Keratolytic Agents Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Keratolytic Agents Market Size Market Share
8.7 South America
8.7.1 South America Keratolytic Agents Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Keratolytic Agents Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Keratolytic Agents Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Keratolytic Agents Revenue, 2018-2029
9.3 By Country, Global Keratolytic Agents Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Keratolytic Agents Market Size, 2018-2029
9.4.2 By Company, U.S. Keratolytic Agents Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Keratolytic Agents Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Keratolytic Agents Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Keratolytic Agents Market Size, 2018-2029
9.5.2 By Company, Europe Keratolytic Agents Sales Volume Market Share, 2022
9.5.3 By Type, Europe Keratolytic Agents Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Keratolytic Agents Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Keratolytic Agents Market Size, 2018-2029
9.6.2 By Company, China Keratolytic Agents Sales Volume Market Share, 2022
9.6.3 By Type, China Keratolytic Agents Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Keratolytic Agents Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Keratolytic Agents Market Size, 2018-2029
9.7.2 By Company, Japan Keratolytic Agents Sales Volume Market Share, 2022
9.7.3 By Type, Japan Keratolytic Agents Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Keratolytic Agents Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Keratolytic Agents Market Size, 2018-2029
9.8.2 By Company, South Korea Keratolytic Agents Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Keratolytic Agents Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Keratolytic Agents Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Keratolytic Agents Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Keratolytic Agents Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Keratolytic Agents Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Keratolytic Agents Market Size, 2018-2029
9.10.2 By Company, India Keratolytic Agents Sales Volume Market Share, 2022
9.10.3 By Type, India Keratolytic Agents Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Keratolytic Agents Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Keratolytic Agents Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Keratolytic Agents Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Keratolytic Agents Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Inc Keratolytic Agents Models, Specifications and Application
10.1.3 Pfizer Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Inc Company Profile and Main Business
10.1.5 Pfizer Inc Recent Developments
10.2 GSK plc
10.2.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.2.2 GSK plc Keratolytic Agents Models, Specifications and Application
10.2.3 GSK plc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 GSK plc Company Profile and Main Business
10.2.5 GSK plc Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.3.2 Novartis AG Keratolytic Agents Models, Specifications and Application
10.3.3 Novartis AG Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis AG Company Profile and Main Business
10.3.5 Novartis AG Recent Developments
10.4 Mylan NV
10.4.1 Mylan NV Company Information, Head Office, Market Area and Industry Position
10.4.2 Mylan NV Keratolytic Agents Models, Specifications and Application
10.4.3 Mylan NV Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Mylan NV Company Profile and Main Business
10.4.5 Mylan NV Recent Developments
10.5 Boehringer Ingelheim International GmbH
10.5.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.5.2 Boehringer Ingelheim International GmbH Keratolytic Agents Models, Specifications and Application
10.5.3 Boehringer Ingelheim International GmbH Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.5.5 Boehringer Ingelheim International GmbH Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.6.2 AstraZeneca Keratolytic Agents Models, Specifications and Application
10.6.3 AstraZeneca Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 AstraZeneca Company Profile and Main Business
10.6.5 AstraZeneca Recent Developments
10.7 Johnson & Johnson Private Limited
10.7.1 Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
10.7.2 Johnson & Johnson Private Limited Keratolytic Agents Models, Specifications and Application
10.7.3 Johnson & Johnson Private Limited Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Johnson & Johnson Private Limited Company Profile and Main Business
10.7.5 Johnson & Johnson Private Limited Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Bayer AG Keratolytic Agents Models, Specifications and Application
10.8.3 Bayer AG Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bayer AG Company Profile and Main Business
10.8.5 Bayer AG Recent Developments
10.9 Merck & Co., Inc
10.9.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.9.2 Merck & Co., Inc Keratolytic Agents Models, Specifications and Application
10.9.3 Merck & Co., Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Merck & Co., Inc Company Profile and Main Business
10.9.5 Merck & Co., Inc Recent Developments
10.10 Bristol-Myers Squibb Company
10.10.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.10.2 Bristol-Myers Squibb Company Keratolytic Agents Models, Specifications and Application
10.10.3 Bristol-Myers Squibb Company Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.10.5 Bristol-Myers Squibb Company Recent Developments
10.11 Cadila Pharmaceuticals
10.11.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.11.2 Cadila Pharmaceuticals Keratolytic Agents Models, Specifications and Application
10.11.3 Cadila Pharmaceuticals Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Cadila Pharmaceuticals Company Profile and Main Business
10.11.5 Cadila Pharmaceuticals Recent Developments
10.12 Lilly
10.12.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.12.2 Lilly Keratolytic Agents Models, Specifications and Application
10.12.3 Lilly Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Lilly Company Profile and Main Business
10.12.5 Lilly Recent Developments
10.13 LEO Pharma A/S
10.13.1 LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
10.13.2 LEO Pharma A/S Keratolytic Agents Models, Specifications and Application
10.13.3 LEO Pharma A/S Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 LEO Pharma A/S Company Profile and Main Business
10.13.5 LEO Pharma A/S Recent Developments
10.14 Cipla Inc
10.14.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Cipla Inc Keratolytic Agents Models, Specifications and Application
10.14.3 Cipla Inc Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Cipla Inc Company Profile and Main Business
10.14.5 Cipla Inc Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.15.2 Aurobindo Pharma Keratolytic Agents Models, Specifications and Application
10.15.3 Aurobindo Pharma Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
10.16 Lupin
10.16.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.16.2 Lupin Keratolytic Agents Models, Specifications and Application
10.16.3 Lupin Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Lupin Company Profile and Main Business
10.16.5 Lupin Recent Developments
10.17 Sumitomo Corporation
10.17.1 Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
10.17.2 Sumitomo Corporation Keratolytic Agents Models, Specifications and Application
10.17.3 Sumitomo Corporation Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Sumitomo Corporation Company Profile and Main Business
10.17.5 Sumitomo Corporation Recent Developments
10.18 Taro Pharmaceutical Industries Ltd
10.18.1 Taro Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.18.2 Taro Pharmaceutical Industries Ltd Keratolytic Agents Models, Specifications and Application
10.18.3 Taro Pharmaceutical Industries Ltd Keratolytic Agents Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Taro Pharmaceutical Industries Ltd Company Profile and Main Business
10.18.5 Taro Pharmaceutical Industries Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Keratolytic Agents Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Keratolytic Agents Market Restraints
Table 3. Keratolytic Agents Market Trends
Table 4. Keratolytic Agents Industry Policy
Table 5. Global Keratolytic Agents Revenue by Company, 2018-2023, US$ million
Table 6. Global Keratolytic Agents Revenue Market Share by Company, 2018-2023
Table 7. Global Keratolytic Agents Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Keratolytic Agents Sales Volume Market Share by Company, 2018-2023
Table 9. Global Keratolytic Agents Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Keratolytic Agents Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Keratolytic Agents Mergers & Acquisitions, Expansion Plans
Table 12. Global Keratolytic Agents Manufacturers Product Type
Table 13. China Keratolytic Agents Revenue by Company, 2018-2023, US$ million
Table 14. China Keratolytic Agents Revenue Market Share by Company, 2018-2023
Table 15. China Keratolytic Agents Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Keratolytic Agents Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Keratolytic Agents Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Keratolytic Agents Import & Export Trends
Table 19. Main Sources of China Keratolytic Agents Import
Table 20. Export Destination of China Keratolytic Agents
Table 21. Global Headquarters and Manufacturing Base of Keratolytic Agents Manufacturers
Table 22. Global Major Manufacturers, Keratolytic Agents Capacity Expansion and Future Plans
Table 23. Global Keratolytic Agents Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Keratolytic Agents Production by Region, 2018-2023, (K Units)
Table 25. Global Keratolytic Agents Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Keratolytic Agents Upstream (Raw Materials)
Table 27. Global Keratolytic Agents Typical Customers
Table 28. Keratolytic Agents Typical Distributors
Table 29. By Type, Global Keratolytic Agents Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Keratolytic Agents Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Keratolytic Agents Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Keratolytic Agents Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Keratolytic Agents Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Keratolytic Agents Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Keratolytic Agents Revenue Market Share, 2018-2029
Table 37. By Country, Global Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Keratolytic Agents Sales Volume Market Share, 2018-2029
Table 39. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Inc Keratolytic Agents Models, Specifications and Application
Table 41. Pfizer Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Inc Company Profile and Main Business
Table 43. Pfizer Inc Recent Developments
Table 44. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 45. GSK plc Keratolytic Agents Models, Specifications and Application
Table 46. GSK plc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. GSK plc Company Profile and Main Business
Table 48. GSK plc Recent Developments
Table 49. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 50. Novartis AG Keratolytic Agents Models, Specifications and Application
Table 51. Novartis AG Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis AG Company Profile and Main Business
Table 53. Novartis AG Recent Developments
Table 54. Mylan NV Company Information, Head Office, Market Area and Industry Position
Table 55. Mylan NV Keratolytic Agents Models, Specifications and Application
Table 56. Mylan NV Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Mylan NV Company Profile and Main Business
Table 58. Mylan NV Recent Developments
Table 59. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 60. Boehringer Ingelheim International GmbH Keratolytic Agents Models, Specifications and Application
Table 61. Boehringer Ingelheim International GmbH Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 63. Boehringer Ingelheim International GmbH Recent Developments
Table 64. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 65. AstraZeneca Keratolytic Agents Models, Specifications and Application
Table 66. AstraZeneca Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. AstraZeneca Company Profile and Main Business
Table 68. AstraZeneca Recent Developments
Table 69. Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
Table 70. Johnson & Johnson Private Limited Keratolytic Agents Models, Specifications and Application
Table 71. Johnson & Johnson Private Limited Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Johnson & Johnson Private Limited Company Profile and Main Business
Table 73. Johnson & Johnson Private Limited Recent Developments
Table 74. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 75. Bayer AG Keratolytic Agents Models, Specifications and Application
Table 76. Bayer AG Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bayer AG Company Profile and Main Business
Table 78. Bayer AG Recent Developments
Table 79. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 80. Merck & Co., Inc Keratolytic Agents Models, Specifications and Application
Table 81. Merck & Co., Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Merck & Co., Inc Company Profile and Main Business
Table 83. Merck & Co., Inc Recent Developments
Table 84. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 85. Bristol-Myers Squibb Company Keratolytic Agents Models, Specifications and Application
Table 86. Bristol-Myers Squibb Company Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bristol-Myers Squibb Company Company Profile and Main Business
Table 88. Bristol-Myers Squibb Company Recent Developments
Table 89. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 90. Cadila Pharmaceuticals Keratolytic Agents Models, Specifications and Application
Table 91. Cadila Pharmaceuticals Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Cadila Pharmaceuticals Company Profile and Main Business
Table 93. Cadila Pharmaceuticals Recent Developments
Table 94. Lilly Company Information, Head Office, Market Area and Industry Position
Table 95. Lilly Keratolytic Agents Models, Specifications and Application
Table 96. Lilly Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Lilly Company Profile and Main Business
Table 98. Lilly Recent Developments
Table 99. LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
Table 100. LEO Pharma A/S Keratolytic Agents Models, Specifications and Application
Table 101. LEO Pharma A/S Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. LEO Pharma A/S Company Profile and Main Business
Table 103. LEO Pharma A/S Recent Developments
Table 104. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Cipla Inc Keratolytic Agents Models, Specifications and Application
Table 106. Cipla Inc Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Cipla Inc Company Profile and Main Business
Table 108. Cipla Inc Recent Developments
Table 109. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 110. Aurobindo Pharma Keratolytic Agents Models, Specifications and Application
Table 111. Aurobindo Pharma Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Aurobindo Pharma Company Profile and Main Business
Table 113. Aurobindo Pharma Recent Developments
Table 114. Lupin Company Information, Head Office, Market Area and Industry Position
Table 115. Lupin Keratolytic Agents Models, Specifications and Application
Table 116. Lupin Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Lupin Company Profile and Main Business
Table 118. Lupin Recent Developments
Table 119. Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
Table 120. Sumitomo Corporation Keratolytic Agents Models, Specifications and Application
Table 121. Sumitomo Corporation Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Sumitomo Corporation Company Profile and Main Business
Table 123. Sumitomo Corporation Recent Developments
Table 124. Taro Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 125. Taro Pharmaceutical Industries Ltd Keratolytic Agents Models, Specifications and Application
Table 126. Taro Pharmaceutical Industries Ltd Keratolytic Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Taro Pharmaceutical Industries Ltd Company Profile and Main Business
Table 128. Taro Pharmaceutical Industries Ltd Recent Developments
List of Figure
Figure 1. Keratolytic Agents Picture
Figure 2. By Revenue, Global Keratolytic Agents Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Keratolytic Agents Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Keratolytic Agents Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Keratolytic Agents Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Keratolytic Agents Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Keratolytic Agents Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Keratolytic Agents Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Keratolytic Agents Share of Global Market, 2018-2029
Figure 10. Global Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Keratolytic Agents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Keratolytic Agents Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Keratolytic Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Keratolytic Agents Domestic VS Export, 2022
Figure 16. Global Keratolytic Agents Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Keratolytic Agents Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Keratolytic Agents Production Market Share & Forecast by Region, 2018-2029
Figure 19. Keratolytic Agents Industry Chain
Figure 20. Keratolytic Agents Procurement Model
Figure 21. Keratolytic Agents Sales Model
Figure 22. Keratolytic Agents Sales Channels, Direct Sales and Distribution
Figure 23. Salicylic Acid
Figure 24. Alpha Hydroxy Acid
Figure 25. Azelaic Acid
Figure 26. Tretinoin
Figure 27. Other
Figure 28. By Type, Global Keratolytic Agents Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Keratolytic Agents Revenue Market Share, 2018-2029
Figure 30. By Type, Global Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Keratolytic Agents Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Keratolytic Agents Price, 2018-2029, (US$/Unit)
Figure 33. Psoriasis
Figure 34. Acne
Figure 35. Other
Figure 36. By Application, Global Keratolytic Agents Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Keratolytic Agents Revenue Market Share, 2018-2029
Figure 38. By Application, Global Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Keratolytic Agents Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Keratolytic Agents Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Keratolytic Agents Revenue Market Share, 2018-2029
Figure 42. By Region, Global Keratolytic Agents Sales Volume Market Share, 2018-2029
Figure 43. North America Keratolytic Agents Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Keratolytic Agents Revenue Market Share, 2022
Figure 45. Europe Keratolytic Agents Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Keratolytic Agents Revenue Market Share, 2022
Figure 47. Asia Pacific Keratolytic Agents Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Keratolytic Agents Revenue Market Share, 2022
Figure 49. South America Keratolytic Agents Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Keratolytic Agents Revenue Market Share, 2022
Figure 51. Middle East & Africa Keratolytic Agents Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Keratolytic Agents Market Share, 2022
Figure 54. By Type, U.S. Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Keratolytic Agents Market Share, 2022
Figure 58. By Type, Europe Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 60. China Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Keratolytic Agents Market Share, 2022
Figure 62. By Type, China Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Keratolytic Agents Market Share, 2022
Figure 66. By Type, Japan Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Keratolytic Agents Market Share, 2022
Figure 70. By Type, South Korea Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Keratolytic Agents Market Share, 2022
Figure 74. By Type, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 76. India Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Keratolytic Agents Market Share, 2022
Figure 78. By Type, India Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Keratolytic Agents Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia Keratolytic Agents Market Share, 2022
Figure 82. By Type, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Keratolytic Agents Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches



Reason to Buy

  • Current and future of Uncategorized Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Uncategorized Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets